| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $231.3M | — | +34.2% |
| Cost of Revenue | $124.0M | — | +38.1% |
| Gross Profit | $107.2M | — | +29.9% |
| R&D Expense | $36.5M | — | +32.9% |
| SG&A Expense | $13.8M | — | +6.9% |
| Operating Income | $36.2M | — | +40.3% |
| Pre-tax Income | $30.0M | — | +10.5% |
| Income Tax | $3.8M | — | +75.2% |
| Net Income | $17.3M | — | -15.1% |
| EPS (Basic) | $0.26 | — | -18.8% |
| EPS (Diluted) | $0.24 | — | -20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $872.3M | +15.2% | +90.8% |
| Short-term Investments | $34.7M | -2.4% | +89.2% |
| Accounts Receivable | $526.5M | +4.4% | +35.8% |
| Inventory | $738.0M | +5.0% | +21.1% |
| Current Assets | $2.62B | +7.5% | +69.2% |
| Total Assets | $3.07B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$29.5M | — | -659.2% |
| Capital Expenditures | $22.2M | — | +32.7% |
| Investing Cash Flow | -$9.8M | — | +41.9% |
| Financing Cash Flow | $163.4M | — | +143.1% |
| Free Cash Flow | -$51.7M | — | -352.1% |
| +58.5% |
| Current Liabilities | $745.7M | -0.0% | +18.6% |
| Long-term Debt | $234.2M | +9.4% | +15.6% |
| Total Liabilities | $982.4M | +4.3% | +26.2% |
| Stockholders' Equity | $1.58B | +8.0% | +66.6% |